The subgroup analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist study, which only enrolled HF patients with preserved EF (LVEF  ≥ 45%), showed that insulin therapy was associated with a 40 % increase in all-cause and cardiovascular mortality compared with DM therapy without insulin [27]. This evidence concerns the gene INS and heart failure.